Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets

Tissue Antigens

Volumn 86, Issue 5, 2015, Pages 368-372

  Resse, M ^a   Paolillo, R ^a   Minucci, B P ^a   Moccia, G ^a   Napoli, C ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Eplet pairs; HLAMatchmaker; Human leukocyte antigen antibodies; Nonself self paradigm

Indexed keywords

EPITOPE; HLA ANTIBODY; ANTIBODY; HLA ANTIGEN;

ADULT; ALLELE; ANALYZER; ANTIBODY RESPONSE; ARTICLE; CASE REPORT; COMPLEMENT FIXATION; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNOASSAY; MIDDLE AGED; PRIORITY JOURNAL; SERODIAGNOSIS; ALGORITHM; CHEMISTRY; GENETICS;

ALGORITHMS; ANTIBODIES; EPITOPES; HLA ANTIGENS; HUMANS;

EID: 84944159932     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12652     Document Type: Article

References (25)

1. Tait BD, Süsal C, Gebel HM et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013: 95: 19-47.
2. Lobashevsky AL. Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation. World J Transplant 2014: 4: 153-67.
3. El-Awar N, Lee JH, Tarsitani C, Terasaki PI. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Hum Immunol 2007: 68: 170-80.
4. Dankers MK, Witvliet MD, Roelen DL et al. The number of aminoacid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004: 77: 1236-9.
5. Muro M, González-Soriano MJ, Salgado G et al. Specific "intra-allele" (IA) and "intra-broad antigen" (IBA) HLA alloantibodies in kidney graft transplantation. Hum Immunol 2010: 71: 857-60.
6. Duquesnoy RJ, Marrari M, Mulder A, Sousa LC, da Silva AS, do Monte SJ. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry. Tissue Antigens 2014: 83: 391-400.
7. Bosch A, Llorente S, Diaz JA et al. Low median fluorescence intensity (MFI) could be a non-safety concept of immunological risk evaluation in patients with shared molecular eplets in kidney transplantation. Hum Immunol 2012: 73: 522-5.
8. El-Awar N, Cook D, Terasaki PI. HLA class I epitopes: a and B loci. Clin Transpl 2006: 79-94.
9. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006: 67: 847-62.
10. Duquesnoy RJ, Marrari M, Mulder A, Claas FH, Mostecki J, Balazs I. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies. Hum Immunol 2012: 73: 267-77.
11. Duquesnoy RJ. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int J Immunogenet 2012: 39: 1-9.
12. Duquesnoy RJ, Marrari M, da M Sousa LC et al. 16th IHIW: a website for antibody-defined HLA epitope registry. Int J Immunogenet 2013: 40: 54-9.
13. Resse M, Paolillo R, Casamassimi A et al. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant. Hum Immunol 2013: 74: 937-41.
14. Zeevi A, Lunz J, Feingold B et al. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant 2013: 32: 98-105.
15. Duquesnoy RJ, Marrari M. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009: 74: 117-33.
16. El-Awar NR, Akaza T, Terasaki PI, Nguyen A. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007: 84: 532-40.
17. Duquesnoy RJ, Marrari M, Jelenik L, Zeevi A, Claas FH, Mulder A. Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays. Hum Immunol 2013: 74: 1271-9.
18. Tonegawa S. Somatic generation of antibody diversity. Nature 1983: 302: 575-81.
19. Kim S, Davis M, Sinn E, Patten P, Hood L. Antibody diversity: somatic hypermutation of rearranged VH genes. Cell 1981: 27: 573-81.
20. Heltemes LM, Manser T. Level of B cell antigen receptor surface expression influences both positive and negative selection of B cells during primary development. J Immunol 2002: 169: 1283-92.
21. Marrari M, Mostecki J, Mulder A, Claas F, Balazs I, Duquesnoy RJ. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets. Transplantation 2010: 90: 1468-72.
22. Hilton HG, Parham P. Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules. Tissue Antigens 2013: 81: 212-20.
23. Battle R, Turner D, Woodroofe N, Clark B. Identified HLA class I epitopes can undergo conformational induced variation due to changes within HLA bound peptides. Immunol Lett 2014: 161: 57-8.
24. Duquesnoy RJ, Marrari M. Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. Transpl Immunol 2011: 24: 164-71.
25. Zeevi A, Marrari M, Feingold B, Webber S, Duquesnoy RJ. Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient. Hum Immunol 2012: 73: 48-51.